Regulatory Update — Week of July 29, 2024 Post author:PacConAdmin Post published:August 2, 2024 Post category:Uncategorized Post comments:0 Comments This week, the FDA published notice of user fee rates for fiscal year 2025. Source: Drug Industry Daily Tags: aaps Read more articles Previous PostQuick Notes: EU News Roundup — Aug. 2, 2024 Next PostBlood-Based Colorectal Cancer Screening Test Gets Thumbs Up From FDA You Might Also Like FDA Seeking Info to Develop Guidances on Host Cell Protein Risk and Biosimilars July 24, 2024 FDA Issues 2024 Priorities for CDER Guidances, BsUFA Research Roadmap February 1, 2024 FDA Decision on Regeneron’s Linvoseltamab Held Back by Third-Party Manufacturer August 28, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
